124 related articles for article (PubMed ID: 11368878)
21. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
22. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
23. [A study of gene amplification and expression of cyclin D1 in hepatocellular carcinoma].
Xu JM; Wen JM; Zhang M; Lü GL; Wu LZ; Wang WS
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):26-30. PubMed ID: 14989924
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
Ahn MJ; Kim BH; Jang SJ; Hong EK; Lee WM; Baik HK; Park HK; Lee CB; Ki M
J Korean Med Sci; 1998 Oct; 13(5):513-8. PubMed ID: 9811181
[TBL] [Abstract][Full Text] [Related]
25. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
[TBL] [Abstract][Full Text] [Related]
26. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
Deane NG; Parker MA; Aramandla R; Diehl L; Lee WJ; Washington MK; Nanney LB; Shyr Y; Beauchamp RD
Cancer Res; 2001 Jul; 61(14):5389-95. PubMed ID: 11454681
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway.
Huang J; Zheng C; Shao J; Chen L; Liu X; Shao J
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):542-549. PubMed ID: 29079187
[TBL] [Abstract][Full Text] [Related]
29. FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma.
Huang HL; Zheng WL; Zhao R; Zhang B; Ma WL
Oncol Rep; 2010 Sep; 24(3):715-20. PubMed ID: 20664978
[TBL] [Abstract][Full Text] [Related]
30. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
33. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical demonstration of cyclins A, B, D1, D3 and E in hepatocellular carcinomas using tissue microarrays].
Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):440-3. PubMed ID: 14633457
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
Zhang YJ; Chen SY; Chen CJ; Santella RM
Mol Carcinog; 2002 Feb; 33(2):125-9. PubMed ID: 11813305
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Matsumoto K; Nishioka M; Hatanaka Y; Omata M
Hepatology; 2000 Oct; 32(4 Pt 1):711-20. PubMed ID: 11003614
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclins D1 and E in human colon adenocarcinomas.
Sutter T; Doi S; Carnevale KA; Arber N; Weinstein IB
J Med; 1997; 28(5-6):285-309. PubMed ID: 9604788
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter.
Park SG; Chung C; Kang H; Kim JY; Jung G
J Biol Chem; 2006 Oct; 281(42):31770-7. PubMed ID: 16940298
[TBL] [Abstract][Full Text] [Related]
40. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.
Du S; Lu L; Miao Y; Jin W; Li C; Xin Y; Xuan S
Lipids Health Dis; 2017 Apr; 16(1):76. PubMed ID: 28407767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
